Weight Loss Risks
- All
- News
- Videos
- Web Stories
-
Late-Night Hunger Isn't Just A Habit, Doctors Say It May Signal Disease
Frequent late-night hunger may reflect hormonal shifts, sleep disruption or metabolic conditions rather than poor self-control.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
From Hair Fall To Brittle Nails: Goa-Based Doctor Shares 10 Signs Of Unbalanced Weight Loss
Not all weight loss is created equal. Sometimes, what looks like progress on the scale may actually hide underlying risks
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
This Magnesium-Packed Fruit Is Quietly Powering Your Heart; Here's How
Bananas are a powerhouse for cardiovascular wellness, primarily because they combine heart-essential minerals with fibre and antioxidants.
-
What Is Jeffing, The Walk-Run Fitness Trend To Help With Weight Loss?
Jeffing involves alternating between set periods of running and brisk walking to increase endurance, reduce injury risk, and manage fatigue
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
GLP-1 Drugs And Muscle Loss: Doctor Warns Of Hidden Side Effects Of Weight Loss Drugs
While GLP-1 drugs are effective for shedding pounds, there are concerns about potential risks and long-term effects.
-
Late-Night Hunger Isn't Just A Habit, Doctors Say It May Signal Disease
Frequent late-night hunger may reflect hormonal shifts, sleep disruption or metabolic conditions rather than poor self-control.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
From Hair Fall To Brittle Nails: Goa-Based Doctor Shares 10 Signs Of Unbalanced Weight Loss
Not all weight loss is created equal. Sometimes, what looks like progress on the scale may actually hide underlying risks
-
Stopping Weight-Loss Injections May Trigger Rapid Weight Regain: Oxford Study
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
-
This Magnesium-Packed Fruit Is Quietly Powering Your Heart; Here's How
Bananas are a powerhouse for cardiovascular wellness, primarily because they combine heart-essential minerals with fibre and antioxidants.
-
What Is Jeffing, The Walk-Run Fitness Trend To Help With Weight Loss?
Jeffing involves alternating between set periods of running and brisk walking to increase endurance, reduce injury risk, and manage fatigue
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
GLP-1 Drugs And Muscle Loss: Doctor Warns Of Hidden Side Effects Of Weight Loss Drugs
While GLP-1 drugs are effective for shedding pounds, there are concerns about potential risks and long-term effects.
